Drug Profile
Apovincamine - Taisho Pharmaceutical
Alternative Names: VA 045Latest Information Update: 18 Jul 2001
Price :
$50
*
At a glance
- Originator Taisho Pharmaceutical
- Class Nootropics; Vasodilators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease; Dementia; Learning disorders
Most Recent Events
- 18 Jul 2001 No-Development-Reported for Alzheimer's disease in Japan (Unknown route)
- 18 Jul 2001 No-Development-Reported for Dementia in Japan (Unknown route)
- 18 Jul 2001 No-Development-Reported for Learning disorders in Japan (Unknown route)